June 2, 2026
Envisioning a New Future for Patients with Inherited Retinal Diseases
Watch the documentary: Follow Lindsey Rambo’s inspiring journey to bring hope, awareness, and support to the patient community
Patient spotlight
Lindsey Rambo, an Opus LCA5 patient, has lived with LCA5, a rare inherited retinal disease, since childhood. Growing up, she navigated a world she could not fully see while facing the uncertainty that comes with a rare genetic condition. Today, Lindsey shares her story to raise awareness of inherited retinal diseases and to inspire hope for a future where advances in genetic medicine may help preserve and restore vision for patients and families affected by these conditions.
Committed to patients with inherited retinal diseases
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment of IRDs and other retinal and refractive disorders.
Watch the Documentary
Hope is what we received when we heard about the potential treatment for Braydon’s rare inherited retinal disease. We are very excited that Opus’ focus is on helping people with rare eye diseases!
– Kellie, Mom of Braydon, RDH12 patient